Navigation Links
Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients
Date:8/16/2011

EAST BRUNSWICK, N.J., Aug. 16, 2011 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) today announced that results from two pivotal KRYSTEXXA® (pegloticase) Phase III clinical studies in patients with refractory chronic gout (RCG) have been published in The Journal of the American Medical Association (JAMA). The data demonstrated that treatment with KRYSTEXXA resulted in significant and sustained reductions in uric acid levels along with clinical improvements in a substantial proportion of RCG patients for six months, a timeframe for demonstrating clinical improvement that is unique in randomized controlled studies of urate-lowering therapies.

The two replicate, randomized, double-blind, placebo-controlled Phase III studies were designed to evaluate the efficacy and tolerability of treatment with KRYSTEXXA 8 mg every two weeks or every four weeks compared to placebo for the management of RCG patients. Pooled results from these studies demonstrated that treatment with KRYSTEXXA every two weeks, the U.S. Food and Drug Administration (FDA)-approved dose, resulted in a statistically significant and sustained reduction in uric acid levels below 6 mg/dL in 42 percent of patients, compared to zero percent of patients receiving placebo (p<0.001).  

In addition, 40 percent of patients with tophi receiving KRYSTEXXA every two weeks experienced complete resolution of one or more tophi, which are deposits of crystalline urate in joints, skin or cartilage, by the final study visit, compared to seven percent of patients on placebo (p=0.002). A tophus complete response was defined as 100 percent reduction in the measured area of at least one tophus without growth of any baseline tophus or appearance of any new tophus.

"When effective lowering of uric acid levels cannot be achieved with oral medications, many gout patients progress to a se
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Savient Pharmaceuticals to Present at the Wedbush Securities 2011 Life Sciences Management Access Conference
2. Savient Pharmaceuticals Reports Second Quarter 2011 Financial Results
3. Savient Pharmaceuticals to Hold Second Quarter 2011 Financial Results Conference Call on Thursday, August 4, 2011
4. Savient Pharmaceuticals Marketing Authorization Application for KRYSTEXXA® Accepted for Review by European Medicines Agency
5. Savient Pharmaceuticals Reports First Quarter 2011 Financial Results
6. Savient Pharmaceuticals Submits European Marketing Authorization Application for KRYSTEXXA®
7. Savient Pharmaceuticals Names Seasoned Pharma Exec Richard Crowley EVP Biopharmaceutical Operations
8. Savient Pharmaceuticals to Present Multiple Abstracts at The European League Against Rheumatism (EULAR) 2011 Annual Congress
9. Savient Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference
10. Savient Pharmaceuticals to Hold First Quarter 2011 Financial Results
11. Savient Pharmaceuticals to Present at the ROTH 23rd Annual OC Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... Mai 2013 Kepner-Tregoe (KT), das ... heute bekannt, dass der Veteran von 13 ... zum Hauptgeschäftsführer ernannt wurde. Geraghty,s Erfahrung umfasst ... er zahlreiche Führungspositionen bei Fertigungsunternehmen innehielt. Er ... der als Kepner-Tregoe Hauptgeschäftsführer gedient hat, in ...
(Date:5/22/2013)... , May 22, 2013   Upsher-Smith ... completion of its global Phase III clinical ... developed program for the management of epilepsy ... technology.  USL255 is specifically engineered to provide ... topiramate blood levels observed with currently available ...
(Date:5/22/2013)... VIEJO, Calif. , May 22, 2013  Avanir Pharmaceuticals, ... management will present an overview of the company at the ... Care Conference , Presentation date: Wednesday May 29, 2013 ... , Jefferies 2013 Global Healthcare Conference , Presentation date: ... E.T. A live webcast ...
Breaking Medicine Technology:Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 2Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 3Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 3Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 4Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences 2
... Advanced Life Sciences Holdings, Inc. (OTC Bulletin ... oral antibiotic, today announced that it has submitted a final ... Phase III clinical program of Restanza in the treatment of ... been engaged in the SPA process with the FDA over ...
... Novo Nordisk, a world leader in diabetes care, and Indy ... the availability of a wide array of resources to help kids ... who has type 1 diabetes, will hand out one of these ... for Life Conference in Orlando this week – ...
Cached Medicine Technology:Advanced Life Sciences Submits Updated Special Protocol Assessment to FDA for Restanza in Community Acquired Bacterial Pneumonia 2Advanced Life Sciences Submits Updated Special Protocol Assessment to FDA for Restanza in Community Acquired Bacterial Pneumonia 3Advanced Life Sciences Submits Updated Special Protocol Assessment to FDA for Restanza in Community Acquired Bacterial Pneumonia 4Advanced Life Sciences Submits Updated Special Protocol Assessment to FDA for Restanza in Community Acquired Bacterial Pneumonia 5Novo Nordisk Announces Resources to Help Support Kids with Diabetes Attending Summer Camp 2Novo Nordisk Announces Resources to Help Support Kids with Diabetes Attending Summer Camp 3Novo Nordisk Announces Resources to Help Support Kids with Diabetes Attending Summer Camp 4Novo Nordisk Announces Resources to Help Support Kids with Diabetes Attending Summer Camp 5Novo Nordisk Announces Resources to Help Support Kids with Diabetes Attending Summer Camp 6
(Date:5/22/2013)... May 22, 2013 Zensah® Compression Apparel ... News article titled "Breast pain while running ... bras could help." According to the article, a ... a substantial amount suffer from breast pain while running ... correct the issue. , Zensah emphasizes the importance ...
(Date:5/22/2013)... 2013 People in the United States have ... water shortages. In much of the world, water shortages are ... Sharon Kleyne. She warns against taking water for granted and ... available so easily in the United States. , Sharon Kleyne ... radio show, heard live or by podcast on World Talk ...
(Date:5/22/2013)... IA (PRWEB) May 22, 2013 Diversity ... piece Handicap This! The performance promotes awareness that ... dreams. The Handicap This! performance will be held Friday, ... High School auditorium. Tickets for Handicap This! can ... This! helps audiences measure the level to which their ...
(Date:5/22/2013)... ARBORA University of Michigan study challenges previous research ... Baseball. , The study, a collaboration between researchers ... Florida, looks deeper into the controversial argument over ... strikes for pitchers of the same race. It ... said Jason Winfree, associate professor of sport management ...
(Date:5/22/2013)... that hospitals may be reaping enormous income for ... bloodstream infections contracted in their intensive care units. ... in the American Journal of Medical Quality ... who develops an avoidable central line-associated bloodstream infection ... for than a similar infection-free patient. Moreover, hospitals ...
Breaking Medicine News(10 mins):Health News:Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners 2Health News:Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners 3Health News:Water Advocate Sharon Kleyne Announces Water Conservation Appreciation 2Health News:Handicap This! Comes to Marion, Iowa 2Health News:U-M study challenges notion that umpires call more strikes for pitchers of same race 2Health News:Hospitals profit when patients develop bloodstream infections 2Health News:Hospitals profit when patients develop bloodstream infections 3Health News:Hospitals profit when patients develop bloodstream infections 4
... Light, or photodynamic, therapy can help preserve the ... stage laryngeal (voice box) cancer, according to a study ... is an effective treatment for early laryngeal squamous cell ... side effects than other therapies, while preserving the voice," ...
... HealthDay Reporter , FRIDAY, Jan. 28 (HealthDay News) -- ... pain exacerbated by lack of control -- with doctors poking ... grows near. Hospice care, however, can give back some ... treating pain and helping both the dying person and the ...
... researchers have come one step closer to understanding how ... many common drugs, including some antibiotics, antihistamines and anti-psychotics, ... is estimated around 40-50% of all drugs in development ... electricity in the heart and, as a result, can ...
... Reporter , FRIDAY, Jan. 28 (HealthDay News) -- Vailia Dennis says ... on anyone else,s timetable. Dennis, 91, of Rancho Bernardo, Calif., ... diagnosed with a fatal heart condition. At the time, she was ... heart condition that I have, is one that should have and ...
... News) -- Celiac disease and Crohn,s disease share several genetic ... makes it hard to absorb nutrients properly, is an inherited ... is damaged by gluten and other protein found in wheat ... inflammatory bowel disease. An international team of researchers conducted ...
... Morris Goodman Cancer Research Centre (GCRC), the Research Institute ... DanaFarber Cancer Institute and Harvard Medical School have discovered ... cancer patients are at risk of relapse, thereby sparing ... unnecessary treatment. For years, clinicians have been ...
Cached Medicine News:Health News:Voice-saver: Light therapy for early-stage laryngeal cancer 2Health News:Voice-saver: Light therapy for early-stage laryngeal cancer 3Health News:More People Choosing Hospice at Life's End 2Health News:More People Choosing Hospice at Life's End 3Health News:Victor Chang scientists unlock the 'gates' on sudden cardiac death 2Health News:Woman's Life Refutes a Hospice Myth 2
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
... The Featured Products are ... Mediflex and are offered ... in regular or extra ... equipped with insulation, flush ...
Medicine Products: